1,721,006 research outputs found
Changes in serum titres of prolactin, somatotropin and thyrotropin induced by fenfluramine in humans.
No full text
[Effect of S-adenosyl-methionine (SAMe) on some endocrine parameters in normal adult subjects].
No full textLack of counteracting effect of liposomes on benserazide-induced hyperprolactinemia
No full textBenserazide induces an increase of serum prolactin in man, possibly as
the result of an impairment of the dopamine effect on the pituitary
and/or on the outer median eminence caused by the inhibition on L-dopa
decarboxylase. On the other hand, liposomes obtained from bovine brain
cortex phospholipids reduced serum prolactin possibly through an effect
of phosphatidylserine on dopamine biosynthesis at the level of tyrosine
hydroxylase. Benserazide, given orally (125 mg) to 5 normal subjects,
induced an increase of serum prolactin that did not change when 300 mg
of phospholipid liposomes were given intravenously 60 min later. An
increase of L-dopa synthesis does not seen to be capable to overcome the
effects of the decarboxylase inhibition
Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans
No full textCarbidopa, at the dose of 250 mg. and benserazide at the dose of 125 mg,
given orally in a single dose to healthy women aged between 23 - 26
years enhance significantly serum prolactin. The effect is not shared by
two other inhibitors of AADC, namely alpha-methyl DOPA (500 mg) and
fentiazac (400 mg). The effect of benserazide is suppressed by
bromocriptine (2.5 mg) and blunted by 1-DOPA (400 mg) given orally
simultaneusly
Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
No full textEffects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
No full text- …
